Lentiboost formulated, GMP-grade; reagent for patient treatment.
Ended Purchase Order Awarded
- Contract number
- 75N90021P00317
- Awardee
-
Revvity Gene Delivery GMBH UEI MSN6VLEJCHC5
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,250
Award facts
- Contract value 100% obligated
- $10,250.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germany
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N90021P00317?
75N90021P00317 was awarded to Revvity Gene Delivery GMBH by NIH Clinical Center (National Institutes of Health) on March 31, 2021.
How much is contract 75N90021P00317 worth?
The government has obligated $10,250 on 75N90021P00317.
Was contract 75N90021P00317 competed?
The extent of competition for 75N90021P00317 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award